EUVIMEDEUVIMED entdecken
ÄquivalenzstudieMultizentrische StudieRandomisierte kontrollierte StudieOpen Access · CC BY 4.0

Erythromycin plus metoclopramide combination therapy compared with erythromycin or metoclopramide monotherapy for postpyloric spiral nasoenteric tube placement: a multicenter, open-label, randomized controlled superiority trial

Silin Liang, Jiajia Huang, Linling He, Yuting Chen, Chenxi Li, Linhui Hu, Xiangwei Huang, Xiangyin Chen, Weisheng Chen, Bei Hu, Cheng Sun, Daoyong Huang und 2 weitere

The American Journal of Clinical Nutrition · 2025

DOI: 10.1016/j.ajcnut.2025.09.043 ↗

Kurz gefasst

Äquivalenzstudie in der Zeitschrift The American Journal of Clinical Nutrition, 2025. Verfasst von Silin Liang und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Critical Care Medicine, Shenzhen People's Hospital (The Second Clinical Medical College, Jinan University, The First Affiliated Hospita…. Hauptthemen laut MEDLINE: Enteral Nutrition, Erythromycin, Gastrointestinal Agents, Intubation, Gastrointestinal. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: For critically ill adults with postpyloric feeding, using prokinetic agents to facilitate transpyloric migration is a sensible strategy, and many randomized controlled trials have demonstrated erythromycin and metoclopramide improve the success rate of postpyloric placement of spiral nasoenteric tubes (NETs). OBJECTIVES: To determine whether a combination of erythromycin and metoclopramide is superior to monotherapy with either agent for facilitating the postpyloric placement of self-propelled spiral NETs in critically ill adults. METHODS: A multicenter, open-label, parallel-group, randomized controlled superiority trial was conducted across the intensive care units of 5 tertiary hospitals in China. Critically ill adults requiring postpyloric feeding were randomly assigned (1:1:1) to receive either erythromycin plus metoclopramide, erythromycin alone, or metoclopramide alone. The primary outcome was successful postpyloric placement. This outcome was analyzed using generalized linear mixed models. RESULTS: A total of 1138 patients were screened for eligibility, among whom 777 required NETs placement. Of them, 256 were assigned to the combination group, 261 to the erythromycin group, and 260 to the metoclopramide group. In the intention-to-treat analysis, the success rate for postpyloric placement was 48.0% (123/256) in the combination group, compared with 45.6% (119/261) in the erythromycin group (odds ratio 0.90; 95% confidence interval: 0.63, 1.27; P = 0.54) and 50.8% (132/260) in the metoclopramide group (odds ratio: 1.13; 95% confidence interval: 0.80, 1.61; P = 0.49). Drug-related adverse events were reported in 30 patients (11.7%) in the combination group, which was higher compared with 11 patients (4.2%) in the metoclopramide group (P = 0.002). CONCLUSIONS: The combination therapy of erythromycin and metoclopramide was not superior to erythromycin or metoclopramide monotherapy in facilitating postpyloric placement of spiral NETs in critically ill patients. However, the combination therapy was associated with a higher incidence of drug side effects compared with the metoclopramide monotherapy. The trial was registered with https://www.chictr.org.cn/showprojEN.html?proj=33960 (trial ID ChiCTR1900022508).

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Enteral NutritionErythromycinGastrointestinal AgentsIntubation, GastrointestinalMetoclopramideAdultAgedFemaleHumansMaleMiddle AgedChinaCritical IllnessDrug Therapy, CombinationPylorus

Stichwörter der Autor:innen

critically ill patientsenteral nutritionpostpyloric placementprokinetic agentsself-propelled nasoenteric tubes

Substanzen

ErythromycinGastrointestinal AgentsMetoclopramide

Autor:innen und Institutionen

  • Department of Critical Care Medicine, Shenzhen People's Hospital (The Second Clinical Medical College, Jinan University, The First Affiliated Hospital, Southern University of Science and Technology), Shenzhen, Guangdong…
  • Department of Critical Care Medicine, Maoming People's Hospital, Maoming, Guangdong, China.
  • Department of Emergency Intensive Care Unit, Huizhou Third People's Hospital, Guangzhou Medical University, Huizhou, Guangdong, China.
  • Department of Emergency Medicine, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, Guangdong, China.
  • Department of Critical Care Medicine, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, Guangdong, China.
  • Department of Intensive Care Unit, Yangjiang City People's Hospital, Yangjiang, Guangdong, China.

Zitieren

APA

Liang, S., Huang, J., He, L., Chen, Y., Li, C., Hu, L., Huang, X., Chen, X., Chen, W., Hu, B., Sun, C., Huang, D., Wang, H., & Chen, C. (2025). Erythromycin plus metoclopramide combination therapy compared with erythromycin or metoclopramide monotherapy for postpyloric spiral nasoenteric tube placement: a multicenter, open-label, randomized controlled superiority trial. The American Journal of Clinical Nutrition. https://doi.org/10.1016/j.ajcnut.2025.09.043

Vancouver

Liang S, Huang J, He L, Chen Y, Li C, Hu L, et al. Erythromycin plus metoclopramide combination therapy compared with erythromycin or metoclopramide monotherapy for postpyloric spiral nasoenteric tube placement: a multicenter, open-label, randomized controlled superiority trial. The American Journal of Clinical Nutrition. 2025. doi:10.1016/j.ajcnut.2025.09.043

BibTeX
@article{Liang2025,
  author = {Liang, Silin and Huang, Jiajia and He, Linling and Chen, Yuting and Li, Chenxi and Hu, Linhui and Huang, Xiangwei and Chen, Xiangyin and Chen, Weisheng and Hu, Bei and Sun, Cheng and Huang, Daoyong and Wang, Hao and Chen, Chunbo},
  title = {Erythromycin plus metoclopramide combination therapy compared with erythromycin or metoclopramide monotherapy for postpyloric spiral nasoenteric tube placement: a multicenter, open-label, randomized controlled superiority trial},
  journal = {The American Journal of Clinical Nutrition},
  year = {2025},
  doi = {10.1016/j.ajcnut.2025.09.043}
}
Kostenlos starten →